

Publisher: Bentham Science Publishers
E-ISSN: 1875-6131|2|2|175-190
ISSN: 1568-0142
Source: Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol.2, Iss.2, 2003-06, pp. : 175-190
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Chemokines as Potential Therapeutic Targets in Atherosclerosis
Current Drug Targets, Vol. 7, Iss. 1, 2006-01 ,pp. :





